Received: 16 July 2017
Accepted: 27 April 2018
First Online: 8 May 2018
Compliance with ethical standards
: Members of the task force have conflicts of interest with respect to this work, but none of them received any financial support to develop these guidelines. Astellas, Abott Japan, Eisai, MSD Japan, Elliquence, Otsuka Pharmacetical, Ono Pharmacetical, Kyowa Hakko Kirin Co., LTD., Sato Healthcare Innovation, Shionogi & Co., LTD., Showa Yakuhin Kako Co., LTD., St. Jude Medical Japan, Daiichi-Sankyo, Daiken Medical Co. LTD., Taisho Toyama Pharmacetical, Sumitomo Dainippon Pharma, Taiho Pharma, Takeda Pharmacetical, Mitsubishi Tanabe Pharma, Tsumura & Co., Teikoku Seiyaku, Terumo, Torii Pharmaceutical, Toray, Drager Medical Japan, Nipro, Eli Lilly Japan, Nippon Kayaku, Nippon Shinyaku Co., LTD., Nippon Zoki, Boehringer Ingelheim Japan, Hisamitsu Pharmaceutical, Bitakain Seiyaku KK., B. Braun Aesculap Japan, Pfizer Japan, Fujifilm sonosite Japan, Boston Scientific Japan, Maruishi Pharmaceutical, Maruho, Mundipharma, Mochida Pharmaceutical, Janssen Pharmacetical KK.